Cigna shares dropped sharply after the company reported unexpectedly weak earnings due to higher healthcare costs in a segment of its insurance business. Executives from the company, which ...
Cigna Group inc. (NYSE: CI) shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.
Cigna (CI) shares ended the last trading session 6.3% higher at $282.41. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.
For the full year 2024, Cigna reported adjusted earnings of $27.33 per share on revenue of $247.1 billion, up 27% from 2023. Looking ahead, Cigna provided a disappointing outlook for 2025.
The Cigna Group reported today their total revenue of $247.1 billion for 2024, compared with $195.3 billion in 2023. This ...
Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...
Shares of The Cigna Group (NYSE:CI – Get Free Report) gapped down prior to trading on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at ...
Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical costs, a trend that’s concerned investors in the sector for months.
Cigna (NYSE:CI) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below summarizes their recent ratings, showcasing the ...
Cigna forecasts annual profit below Wall Street ... sponsored plans drove up expenses in its backup insurance product. Shares of the health insurer fell more than 10% in early trading.
It’s been a while since I last covered Cigna (NYSE:CI) back in February of ... Plus, with a forward PE of just 9.9, share repurchases are highly accretive to the bottom line, with a 10% earnings ...
Like other health insurance companies, Cigna has also struggled to rein in rising medical expenses. The company reported $3.4 billion in net income, or $12.12 per share, for the full year of 2024 ...